COVID-19 vaccine: ICMR urges institutes chosen for Bharat Biotech's COVAXIN to complete recruitment for human trials by 7 July
The ICMR envisages launching the vaccine for public health use by 15 August after completion of all clinical trials, as per a letter to institutions conducting trials.
The trials will give 45 volunteers two doses, a month apart but it won't be available for widespread use for 12 to 18 months.
Trials are being done using arthritis, HIV and a combination of other existing drugs to treat the novel coronavirus.
The quarantine period of 14 days being followed worldwide is good enough to observe a person suspected of being sick.
These drugs are good candidates for treating the disease to start with, since there are no treatments for the new coronavirus.
Chinese docs use plasma from people recovered from coronavirus to treat those still battling the illness
WHO said that this was a “very valid” approach but that it was important to get the timing right to maximize the boost to a patient’s immunity.
The flu-like disease officially named COVID-19 can be deadly but there are no proven treatments or vaccines for it.
Dubious advisory by Ministry of AYUSH recommends homoeopathy, Unani to 'prevent' coronavirus infection
This isn't the first time the Ministry of AYUSH has faced heat for propagating pseudoscience as alternative medicine.